Pharmaceuticals Financial Models

A medicine can fund years of research before losing sales rapidly when exclusivity ends. New launches must replace that income, but development spending does not guarantee an approved product. A pharmaceutical forecast needs to reflect the age of the portfolio as well as its current growth.

JNJ_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Johnson & Johnson logo

Johnson & Johnson

Johnson & Johnson is a diversified global healthcare leader engaged in the research, development, manufacture, and sale of pharmaceutical products and medical devices.

MRK_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Merck & Co. logo

Merck & Co.

Merck is a global healthcare company, known as MSD outside the US and Canada, that discovers, develops, and provides innovative prescription medicines, biologic therapies, vaccines, and animal health products.

PFE_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Pfizer logo

Pfizer

Pfizer is a global biopharmaceutical company that discovers, develops, manufactures, and sells innovative medicines and vaccines across primary care, specialty care, and oncology therapeutic areas.

ABBV_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
AbbVie logo

AbbVie

AbbVie is a global, research-based biopharmaceutical company that discovers and delivers innovative medicines and aesthetic products.

BMY_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Bristol Myers Squibb logo

Bristol Myers Squibb

Bristol Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

LLY_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Lilly (Eli) logo

Lilly (Eli)

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and markets human medicines, with a dominant focus on cardiometabolic diseases, oncology, immunology, and neuroscience.

AMGN_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Amgen logo

Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics, focusing on areas of high unmet medical need.

GILD_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Gilead Sciences logo

Gilead Sciences

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercialises innovative medicines in areas of unmet medical need.

VTRS_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Viatris logo

Viatris

Viatris is a global healthcare company formed by the merger of Mylan and Pfizer's Upjohn business, manufacturing and distributing off-patent branded drugs, complex generics, and standard generics worldwide.

REGN_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a fully integrated biotechnology company that discovers, develops, manufactures, and commercialises medicines for serious diseases.

VRTX_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company that discovers, develops, and commercialises transformative medicines for people with serious diseases.

BIIB_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Biogen logo

Biogen

Biogen is a global biotechnology company that discovers, develops, and delivers therapies for neurological, immunological, and rare diseases, including multiple sclerosis and Alzheimer's treatments.

ZTS_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Zoetis logo

Zoetis

Zoetis is the world's largest animal health company, discovering, developing, manufacturing, and commercialising medicines, vaccines, and diagnostic products.

MRNA_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Moderna logo

Moderna

Moderna is a pioneering biotechnology company that develops messenger RNA (mRNA) therapeutics and vaccines.

INCY_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Incyte logo

Incyte

Incyte Corporation is a global commercial-stage biopharmaceutical company focused on the discovery, development, and commercialisation of proprietary therapeutics, primarily in haematology, oncology, and inflammation and autoimmunity (IAI).

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview